Pharmacological possibilities of prolongation of atopic dermatitis remissions
Year: 2024
Type: article
Abstract: Atopic dermatitis (AD) is a common chronic recurrent immune-dependent pruritic dermatosis with a typical clinical picture and a damaging effect on the patient’s quality of life. The mechanism of symptom development includes genetic predisposition, defect in the barrier function of the skin and innate and adaptive immunity, and exposure to environmental triggers, infectious agents, allergens and mechanisms of comorbidities. The chronic nature of the dermatosis, the sharply reduced quality of life of patients with AD and poor adherence of patients to treatment create difficulties on the way to effective therapy of patients. These difficulties can be overcome by the proactive use of tacrolimus ointment (Protopic®) in the external therapy of patients with AD, which, after steroid suppression of the acute phase of exacerbation, applied twice a week, can significantly increase the duration of the achieved remission, improve the quality of life of patients and increase their adherence to treatment. The given brief analysis of the literature data and the results of our own observations confirm the high efficacy of the proactive use of Protopic® ointment in prolonging the remissions of atopic dermatitis.
DOI: 10.25208/vdv16303
Author: Nikolay G. Kochergin
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4403778090